NCT04672330
- Conditions
- Neoadjuvant Immunotherapy of Cisplatin-ineligible High Risk Upper Urinary Tract Urothelial Carcinoma
- Locations
-
- Shanghai Renji Hospital Shanghai, Shanghai Municipality, China
Clinical trial condition
Neoadjuvant Immunotherapy of Cisplatin-ineligible High Risk Upper Urinary Tract Urothelial Carcinoma
Explore clinical trials studying Neoadjuvant Immunotherapy of Cisplatin-ineligible High Risk Upper Urinary Tract Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies